EMA-2023-0002-V102

Type IB variation for application EMA-2023-0002. Type IB variation: Formulation Change for Respiralimab — routine update

Variation Number
EMA-2023-0002-V102
Type
Type IB
Application
EMA-2023-0002
Change
CHG-2023-0102
Status
Approved
Fee
€2,745
Submitted
2023-08-10
Approved
2023-09-12
Description

Type IB variation: Formulation Change for Respiralimab — routine update